Showing results (271-280 of 454) with videos related to

Sort By:
Pageof 46
Annals of the New York Academy of Sciences|September 15, 1994
Rat pancreatic AR42J cells. Amphicrine cells as an in vitro model to study peptide hormone receptor regulationS Rosewicz, G Ahnert-Hilger, H Haller, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|October 23, 2008
Polymorphisms in perilipin gene (PLIN) are not associated with obesity and weight variation in people with high risk of type 2 diabetesA Bergmann, J Li, M Reimann, et al.
Diabetologia|December 1, 1995
Treatment of symptomatic diabetic peripheral neuropathy with the anti-oxidant alpha-lipoic acid. A 3-week multicentre randomized controlled trial (ALADIN Study)D Ziegler, M Hanefeld, K J Ruhnau, et al.
Diabetes Care|September 10, 1999
Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a 7-month multicenter randomized controlled trial (ALADIN III Study). ALADIN III Study Group. Alpha-Lipoic Acid in Diabetic NeuropathyD Ziegler, M Hanefeld, K J Ruhnau, et al.
Diabetologia|July 14, 1998
Relationship between fasting plasma glucose, atherosclerosis risk factors and carotid intima media thickness in non-diabetic individualsT Temelkova-Kurktschiev, C Koehler, F Schaper, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|January 20, 2011
Relationship between HbA1c on target, risk of silent hypoglycemia and glycemic variability in patients with type 2 diabetes mellitusB Engler, C Koehler, C Hoffmann, et al.
Pharmacology & Therapeutics|January 27, 2009
An update on preventive and regenerative therapies in diabetes mellitusM Reimann, E Bonifacio, M Solimena, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|February 19, 2009
Changes in insulin resistance and cardiovascular risk induced by PPARgamma activation have no impact on RBP4 plasma concentrations in nondiabetic patientsA Pfützner, T Schöndorf, M Hanefeld, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|October 24, 2007
Visfatin: a putative biomarker for metabolic syndrome is not influenced by pioglitazone or simvastatin treatment in nondiabetic patients at cardiovascular risk -- results from the PIOSTAT studyA Pfützner, M Hanefeld, G Lübben, et al.
Acta Diabetologica|October 3, 2002
Insulin-resistant patients with type 2 diabetes mellitus have higher serum leptin levels independently of body fat massS Fischer, M Hanefeld, S M Haffner, et al.
Pageof 46